NicholasAlexanderVitanzaMD
Pediatric Hematology & Oncology • Seattle, WAPediatric Neuro-Oncology
Pediatric Neuro-Oncologist at Seattle Children's Hospital and Investigator at the Fred Hutchinson Cancer Research Center
Dr. Vitanza is on Doximity
As a Doximity member you'll join over a million verified healthcare professionals in a private, secure network.
- Connect with other colleagues in the same hospital or clinic
- Search all U.S. specialist profiles and refer a patient
- Read the latest clinical news and earn CME/CEU credits
Office
4800 Sand Point Way Ne
Seattle, WA 98105- Is this information wrong?
Education & Training
Stanford UniversityFellowship, Pediatric Neuro-Oncology, 2014 - 2016
NYU School of MedicineFellowship, Pediatric Hematology/Oncology, 2011 - 2014
SUNY Stony Brook University Hospital & Medical CenterResidency, Pediatrics, 2008 - 2011
American University of the Caribbean School of MedicineClass of 2008
Certifications & Licensure
AK State Medical License 2021 - 2022
WA State Medical License 2016 - 2023
CA State Medical License 2014 - 2018
NY State Medical License 2011 - 2019- American Board of Pediatrics Pediatrics
- American Board of Pediatrics Pediatric Hematology-Oncology
Awards, Honors, & Recognition
- Young Investigator Travel Stipend Award American Society of Pediatric Hematology/Oncology, 2014
- Research Training Award for Fellows American Society of Hematology, 2013
Clinical Trials
Publications & Presentations
PubMed
- Considerations when treating high-grade pediatric glioma patients with immunotherapy.Erin E. Crotty, Kira Downey, Lauren Ferrerosa, Catherine Flores, Bindu Hegde, Scott Raskin, Eugene Hwang, Nicholas A Vitanza, Hideho Okada> ;Expert Review of Neurotherapeutics. 2021 Feb 1
- Care Coordination in a SARS-CoV-2-infected Child With Newly Diagnosed Medulloblastoma and Fanconi Anemia.Mary T Field, Alayne Chapple, Corrine Hoeppner, Julie R Boiko, Amy Tellinghuisen, Sarita Joshi, Nicholas A Vitanza> ;Journal of Pediatric Hematology Oncology. 2020 Nov 23
- 1 citationsOptimal therapeutic targeting by HDAC inhibition in biopsy-derived treatment-naïve diffuse midline glioma models.Nicholas A Vitanza, Matt C Biery, Carrie Myers, Eric Ferguson, Ye Zheng, Emily J. Girard, Justyna M Przystal, Giulia Park, Alyssa Noll, Fiona Pakiam, Conrad A Winter, ...> ;Neuro-oncology. 2021 Mar 25
- Join now to see all
Press Mentions
- Trials Underway Using Experimental CAR T-cell Therapy for Deadly Childhood Brain CancerNovember 5th, 2020
- First Patient Treated with Experimental Therapy for Deadly Childhood Brain CancerNovember 5th, 2020
- AeroPress Grants Cancer Research Award to Dr. Nicholas VitanzaMarch 26th, 2021
Grant Support
- Research Training Award for FellowsAmerican Society of Hematology2013–2014
Hospital Affiliations
Seattle Children's HospitalSeattle, Washington
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
